Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy.

Boyle AJ, Shih H, Hwang J, Ye J, Lee B, Zhang Y, Kwon D, Jun K, Zheng D, Sievers R, Angeli F, Yeghiazarians Y, Lee R.

Exp Gerontol. 2011 Jul;46(7):549-59. doi: 10.1016/j.exger.2011.02.010. Epub 2011 Mar 3.

2.

Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.

Niemann M, Herrmann S, Hu K, Breunig F, Strotmann J, Beer M, Machann W, Voelker W, Ertl G, Wanner C, Weidemann F.

JACC Cardiovasc Imaging. 2011 Jun;4(6):592-601. doi: 10.1016/j.jcmg.2011.01.020.

3.

Intermedin suppresses pressure overload cardiac hypertrophy through activation of autophagy.

Chen H, Wang X, Tong M, Wu D, Wu S, Chen J, Wang X, Wang X, Kang Y, Tang H, Tang C, Jiang W.

PLoS One. 2013 May 29;8(5):e64757. doi: 10.1371/journal.pone.0064757. Print 2013.

4.

Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.

Garcia AG, Wilson RM, Heo J, Murthy NR, Baid S, Ouchi N, Sam F.

Am J Physiol Heart Circ Physiol. 2012 Sep 1;303(5):H587-96. doi: 10.1152/ajpheart.00298.2012. Epub 2012 Jun 22.

5.

Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome.

Yiu KH, Marsan NA, Delgado V, Biermasz NR, Holman ER, Smit JW, Feelders RA, Bax JJ, Pereira AM.

Eur J Endocrinol. 2012 Jan;166(1):27-34. doi: 10.1530/EJE-11-0601. Epub 2011 Oct 17.

6.

Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.

Mark PB, Johnston N, Groenning BA, Foster JE, Blyth KG, Martin TN, Steedman T, Dargie HJ, Jardine AG.

Kidney Int. 2006 May;69(10):1839-45.

7.

Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.

Cao N, Wong YG, Rosli S, Kiriazis H, Huynh K, Qin C, Du XJ, Kemp-Harper BK, Ritchie RH.

Circ Heart Fail. 2015 May;8(3):572-81. doi: 10.1161/CIRCHEARTFAILURE.114.001699. Epub 2015 Mar 3.

8.

Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.

Suzuki K, Satoh K, Ikeda S, Sunamura S, Otsuki T, Satoh T, Kikuchi N, Omura J, Kurosawa R, Nogi M, Numano K, Sugimura K, Aoki T, Tatebe S, Miyata S, Mukherjee R, Spinale FG, Kadomatsu K, Shimokawa H.

Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):636-46. doi: 10.1161/ATVBAHA.115.306686. Epub 2016 Feb 25.

9.

Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.

Xu X, Fassett J, Hu X, Zhu G, Lu Z, Li Y, Schnermann J, Bache RJ, Chen Y.

Hypertension. 2008 Jun;51(6):1557-64. doi: 10.1161/HYPERTENSIONAHA.108.110833. Epub 2008 Apr 7.

10.

Cardiomyocyte-specific Bmal1 deletion in mice triggers diastolic dysfunction, extracellular matrix response, and impaired resolution of inflammation.

Ingle KA, Kain V, Goel M, Prabhu SD, Young ME, Halade GV.

Am J Physiol Heart Circ Physiol. 2015 Dec 1;309(11):H1827-36. doi: 10.1152/ajpheart.00608.2015. Epub 2015 Oct 2.

11.

Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge.

Miller EJ, Calamaras T, Elezaby A, Sverdlov A, Qin F, Luptak I, Wang K, Sun X, Vijay A, Croteau D, Bachschmid M, Cohen RA, Walsh K, Colucci WS.

J Am Heart Assoc. 2015 Dec 31;5(1). pii: e002277. doi: 10.1161/JAHA.115.002277.

12.

Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise.

Watson PA, Reusch JE, McCune SA, Leinwand LA, Luckey SW, Konhilas JP, Brown DA, Chicco AJ, Sparagna GC, Long CS, Moore RL.

Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H246-59. Epub 2007 Mar 2.

13.

Bovine model of chronic ischemic cardiomyopathy: implications for ventricular assist device research.

Bartoli CR, Sherwood LC, Giridharan GA, Slaughter MS, Wead WB, Prabhu SD, Koenig SC.

Artif Organs. 2013 Dec;37(12):E202-14. doi: 10.1111/aor.12129. Epub 2013 Jul 22.

PMID:
23876076
14.

Mechanical function, glycolysis, and ultrastructure of perfused working mouse hearts following thoracic aortic constriction.

Dunn ME, Manfredi TG, Cosmas AC, Vetter FJ, King JN, Rodgers RL.

Cardiovasc Pathol. 2011 Nov-Dec;20(6):343-51. doi: 10.1016/j.carpath.2010.12.003. Epub 2011 Feb 4.

PMID:
21296006
15.

Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.

Li XM, Ma YT, Yang YN, Liu F, Chen BD, Han W, Zhang JF, Gao XM.

Clin Exp Pharmacol Physiol. 2009 Nov;36(11):1054-61. doi: 10.1111/j.1440-1681.2009.05243.x. Epub 2009 Jun 29.

PMID:
19566828
16.

Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation.

Higashikuni Y, Tanaka K, Kato M, Nureki O, Hirata Y, Nagai R, Komuro I, Sata M.

J Am Heart Assoc. 2013 Nov 18;2(6):e000267. doi: 10.1161/JAHA.113.000267.

17.

Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice.

Ramratnam M, Sharma RK, D'Auria S, Lee SJ, Wang D, Huang XY, Ahmad F.

J Am Heart Assoc. 2014 Aug 4;3(4). pii: e000899. doi: 10.1161/JAHA.114.000899.

18.
19.

Heart angiotensin II-induced cardiomyocyte hypertrophy suppresses coronary angiogenesis and progresses diabetic cardiomyopathy.

Masuda T, Muto S, Fujisawa G, Iwazu Y, Kimura M, Kobayashi T, Nonaka-Sarukawa M, Sasaki N, Watanabe Y, Shinohara M, Murakami T, Shimada K, Kobayashi E, Kusano E.

Am J Physiol Heart Circ Physiol. 2012 May 1;302(9):H1871-83. doi: 10.1152/ajpheart.00663.2011. Epub 2012 Mar 2.

20.

Cardiac remodeling caused by transgenic overexpression of a corn Rac gene.

Elnakish MT, Awad MM, Hassona MD, Alhaj MA, Kulkarni A, Citro LA, Sayyid M, Abouelnaga ZA, El-Sayed O, Kuppusamy P, Moldovan L, Khan M, Hassanain HH.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H868-80. doi: 10.1152/ajpheart.00807.2010. Epub 2011 May 27.

Supplemental Content

Support Center